Dermatology Times, January 2019 (Vol. 40, No. 1)

January 07, 2019

In this table, we highlight some of the forthcoming changes to the Medicare Physician Fee Schedule (PFS) from the Centers for Medicare & Medicaid Services (CMS).

January 07, 2019

Outpatient dermatology services can be available to any patient. However, according to recent research, that doesn’t mean all patients access or take advantage of this clinical care in the same way.

January 07, 2019

Robot dermatologists aren’t yet seeing patients for routine care, but artificial intelligence (AI) and other technology tools are growing in popularity throughout the industry. Learn more about how these advances in technology are impacting practices.

January 07, 2019

Treatment options for metastatic melanoma have greatly improved, including in the adjuvant setting, and these advances are reflected in the recently updated American Academy of Dermatology clinical guidelines on the management of primary cutaneous melanoma. Find out what has changed in this article.

January 07, 2019

Artificial intelligence (AI) tools are steadily growing in popularity throughout medicine, particularly in dermatology. But does AI pose a threat to dermatologists? Find out in this article.

January 04, 2019

In this article, Katja Reuter, Ph.D. critiques a study by Katz and colleagues on the effectiveness of using digital platforms to recruit for an atopic dermatitis study. 

January 04, 2019

Do you know the warning signs of life threatening purpura? Dr. Roderick Hay outlines what you need to know about potentially life-threatening conditions involving purpura.

January 04, 2019

Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.

January 03, 2019

What exactly is digital health? Dr. Steve Xu tackles this question in this month's Innovation column.

January 03, 2019

In this article, we take a look at the future of dermatology, including the rise of medical devices and drug costs.

January 03, 2019

The FDA has reversed a long-standing guidance stating that sponsors of clinical trials for atopic dermatitis (AD) in pediatrics need not start the trial in adults first. Here's what you need to know.

January 03, 2019

Asana BioSciences announced that the U.S. Food and Drug Administration granted fast-track designation for the investigational ASN002, an oral treatment for moderate-to-severe atopic dermatitis. Learn more in this article.

January 03, 2019

Sandoz, a division of Novartis, announced that the U.S. Food and Drug Administration approved its biosimilar, adalimumabadaz (Hyrimoz, Novartis AG). 

January 03, 2019

The cost of clinical trials to get a dermatology drug to market may cost as much as $25 million, which is slightly above a median of $19 million, according to the latest research.

January 03, 2019

The American Academy of Dermatology annual meeting will be held from March 1-5 in Washington, D.C.

January 03, 2019

The National Psoriasis Foundation and the National Eczema Association have awarded Procter & Gamble’s Tide Free and Gentle Liquid Laundry Detergent and Tide PODS Free and Gentle Laundry Detergent a “Seal of Recognition” and “Seal of Acceptance” for people with eczema or sensitive skin.

January 02, 2019

When can a physician disclose protected health care information? Dr. David J. Goldberg addresses this question in this month's Legal Eagle column.

January 02, 2019

In this article, Dr. Ronald G. Wheeland offers his point of view on how to define success in dermatology.

January 02, 2019

In this month's Cosmetic Conundrums, Dr. Draelos explains cleanser mildness, the chemical characteristics of mild cleansers and how these cleansers are tested.